1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "1693766-04-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-107477

    Epigenetic Reader Domain Cancer
    GSK8573 (compound 23) is an inactive control compound for GSK2801. GSK8573 has binding activity to BRD9 with a Kd value of 1.04 μM and is inactive against BAZ2A/B and other bromodomain familiy.